Eyelid lesions w Dr Sid Ogra.

Dr Louise Kuegler and Dr Sid Ogra explore the assessment and management of eyelid lesions in primary care through a clinical case of a 67-year-old woman with a non-healing eyelid lesion. They discuss how to distinguish benign from malignant lesions, highlight key red flags such as lash loss, non-healing or changing lesions, and emphasise the importance of early recognition and timely referral. The episode covers common conditions including actinic keratosis, basal cell carcinoma and melanoma, alongside practical strategies such as thorough history-taking, clinical intuition and the use of photography for monitoring. Preventive approaches, including sun protection and awareness of risk factors, are also discussed to support better patient outcomes.

Practical Clinical Pearls:
Most eyelid lesions are benign, however due to their functional location, larger lesions may still require removal.
Malignant lesions are usually treatable if identified early.
Red flags to watch for include loss of eyelashes, non-healing lesions or persistent “styes” beyond three months, bleeding and ulceration.
If the diagnosis is uncertain, refer early.

Speaker Bio:
Dr Sid Ogra, MBChB, FRANZCO
Specialist in Oculoplastics (eyelid and tear duct disorders) – adults and children
Specialist in cataract surgery, including premium lenses and refractive correction

Dr Sid Ogra is a well-established ophthalmologist with subspecialty expertise in oculoplastics and a busy cataract surgery practice. He provides care across Auckland and Queenstown, seeing both adult and paediatric patients.

Sid graduated with distinction from the University of Auckland and completed his ophthalmology training across Auckland, Rotorua and Wellington. He then undertook an Oculoplastic Fellowship in Hereford, UK in 2019, further refining his surgical skills in eyelid and tear duct disorders.

He has also completed observerships at the Byers Eye Institute at Stanford in the USA and Samsung Medical Centre in Seoul, South Korea, gaining additional international experience in advanced ophthalmic care.

Sid is committed to a collaborative approach, working closely with patients to ensure they are well informed about their condition and treatment options, and supporting shared decision-making to achieve the best possible outcomes.

Resources:
Bernardini FP. Management of malignant and benign eyelid lesions. Current Opinion in Ophthalmology. 2006;17(5):480–484.
Sun MT, Huang S, Huilgol SC, Selva D. Eyelid lesions in general practice. Australian Journal of General Practice. 2019;48(8):509–514.

Listen Here:

https://podcasts.apple.com/nz/podcast/eyelid-lesions-w-dr-sid-ogra/id1845748299?i=1000767073231

https://open.spotify.com/episode/5M1WuUoP90HGOkeqdDWVvk?si=4a9ff98ac1944724